Astellas Pharma | 4503 - Loan Capital

Stock Price
1,724.00
Daily Change
23.00 1.35%
Monthly
4.55%
Yearly
-5.01%
Q3 Forecast
1,683.14

Astellas Pharma reported JPY558.08B in Loan Capital for its fiscal quarter ending in June of 2025.



Financials
Stock Price JPY
Assets JPY 3335.83B
Cash and Equivalent JPY 188.37B
Cost of Sales JPY 94.83B
Current Assets JPY 1293.33B
Current Liabilities JPY 1107.94B
Debt JPY 831.43B
Dividend Yield 5.22
EBIT JPY 92.54B
EBITDA JPY 140.35B
Employees 14.75K
EPS Earnings Per Share JPY 38.22
Equity Capital and Reserves JPY 1481.79B
Gross Profit on Sales JPY 410.97B
Interest Expense on Debt JPY 3.91B
Interest Income JPY 4.12B
Loan Capital JPY 558.08B
Market Capitalization JPY 3086.15B
Net Income JPY 68.42B
Operating Expenses JPY 413.25B
Operating Profit JPY 92.54B
Ordinary Share Capital JPY 1.79B
PE Price to Earnings JPY 9.35
Pre-Tax Profit JPY 90.42B
Sales Revenues JPY 505.79B
Selling and Administration Expenses JPY 197B
Stock JPY 297.26B
Trade Creditors JPY 165.89B
Trade Debtors JPY 699.51B

Loan Capital Change Date
Astellas Pharma JPY 558.08B 6.82B Jun/2025
Chugai Pharma JPY 0 0 Mar/2025
Daiichi Sankyo JPY 100.84B 96M Jun/2025
Eisai JPY 99.84B 9M Jun/2025
Kyowa Hakko Kirin JPY 0 24.12B Mar/2025
M3 JPY 20.56B 780M Jun/2025
Otsuka Holdings JPY 153.76B 27.32B Jun/2025
Shionogi JPY 18.09B 328M Jun/2025
Sumitomo Dainippon JPY 259.06B 75M Jun/2025
Takeda JPY 4.13T 168.47B Jun/2025
Terumo JPY 99.87B 59.97B Jun/2025